It should be noted that administration of recombinant IL-33 (rIL-33) exacerbated cisplatin-induced AKI in wild-type mice, however not in CD4-deficient mice, suggesting that CD4+ T cells mediated the injurious effects of IL-33. Here, IL33 is linked to acute kidney injury.